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and screening of a one-bead one-peptide combinatorial library to identify novel substrates for FAK. Using a solid-phase
colorimetric antibody tagging detection platform, the peptide beads phosphorylated by FAK were sequenced via Edman
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The combination of results gathered from both colorimetric and radioisotope kinase assays led to the rational design of a
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The ability for a cell to sense and to adapt changes in its local
microenvironment is mediated through the regulation of
macromolecular protein complexes called focal adhesions [1,2].
Focal adhesions comprise a diverse array of enzymes and scaffold-
ing proteins that activate signaling cascades leading to changes in
cell behavior [3]. One of the first enzymes found at focal adhesions
was the nonreceptor cytoplasmic protein tyrosine kinase focal
adhesion kinase (FAK, p125FAK) [4]. Kinases are phosphotransferase
enzymes and FAK specifically reacts at tyrosine residues.
Since its discovery, FAK activation has been shown through
integrin-mediated cell adhesion and growth factor receptors [5,6].
Upon activation, FAK becomes autophosphorylated on residue
Y397 and undergoes a conformational change to facilitate binding
of additional kinases such as v-Src [7,8]. The identification of protein
substrates and accessory proteins has given insight into how FAK
plays a pivotal role in cell proliferation, survival, and migration. The
phosphorylation of residue Y397 recruits Src to the active site where
it phosphorylates additional residues such as Y925 that allows for
Grb2 association and subsequent activation of the MAP kinase
signaling pathway [9,10]. The phosphorylation of Y397 was also
shown to promote the formation of protein–protein interactions
with PI3K and p53 to regulate apoptosis [11–13]. Other notable
substrates and accessory proteins for FAK include p130Cas, paxillin,
talin, Grb7, andGTPase Regulator Associatedwith FAK (GRAF) [14–18].
The overexpression and constitutive activity of FAK have been
associated with a number of cancers [19–24]. In ovarian and acute
myeloid leukemia, FAK expression levels have been correlated with02–311disease severity suggesting protein expression levels as a prognos-
tic indicator [25,26]. The development of selective small molecule
FAK inhibitors has given some insights into how FAK triggers
dysregulation within cellular processes and promotes tumorigene-
sis and metastasis [27]. These small molecule inhibitors have been
shown to prevent tumor progression implicating FAK as an
attractive target for anticancer therapeutics [28–31]. Recently, dual
inhibitors of FAK and insulin growth factor I receptor have shown
promise in phase I clinical trials [32].Copyright © 2015 European Peptide Society and John Wiley & Sons, Ltd.
FAK SUBSTRATE PEPTIDESAlthough small molecule inhibitors of FAK are being developed,
there still exists a need for FAK-specific peptide-based probes for
both enzyme activity and competition assays. Further, these
substrates may guide the development of peptide biosensors and
next generation FAK inhibitors as novel anticancer therapeutics.
Herein, we aim to understand substrate specificity of FAK through
the identification of novel peptide substrates. A one-bead one-
peptide combinatorial library was synthesized and assayed using a
colorimetric antibody tagging system to identify those peptide se-
quences that are phosphorylated by FAK. Validation of peptide sub-
strates was performed by [γ-32P] ATP isotopic labeling assays. Based
on trends observed from the phosphoacceptor activity of the library
peptides, additional substrates were designed, synthesized, and
evaluated. This study marks the first time that short peptide sub-
strates capable of being phosphorylated by FAK have been reported.30
3Materials and Methods
Unless otherwise mentioned, all reagents and supplies for solid-
phase peptide synthesis and associated assays were obtained from
Sigma Aldrich (St. Louis, MO, USA), Novabiochem (Billerica, MA,
USA), Fisher Scientific (Pittsburg, PA, USA), or VWR (Radnor, PA,
USA). Specific resins used for peptide synthesis were (i) NovaSyn
TG, ‘TentaGel’, resin beads, 90μm diameter, substitution of
0.27mmol/g and (ii) Wang resin (polystyrene beads, 90μm,
100–200mesh, substitution of Fmoc-lys(boc)-OH varied from
0.27 to 0.66mmol/g, Novabiochem). Monoclonal mouse anti-
phosphotyrosine IgG and alkaline phosphatase (AP)-goat anti-
mouse IgG conjugate were obtained from Zymed Laboratories,
Inc. (San Francisco, CA, USA). BM purple AP substrate was obtained
from Roche Applied Science (Indianapolis, IN, USA); Whatman
Phosphocellulose (p81) 2.5 cm paper discs, Fisher; [γ-32P] ATP
(10mCi/ml, 3000Ci/mmol, IsoBlue stabilized) was obtained from
MP Biomedicals (Santa Ana, CA, USA) (formerly ICN Biomedicals);
Scintisafe Plus 50% liquid scintillation fluid, Fisher; Library Screening
column: 1.5×12 cm, 20ml bed volume polypropylene chromatog-
raphy column with filter membrane, fitted with a stopcock at the
bottom, Bio-Rad Laboratories (Hercules, CA, USA). Full-length ac-
tive recombinant human FAK tyrosine kinase was purchased from
Invitrogen (Life Technologies, Grand Island, NY, USA) as a GST-
tagged protein expressed in sf9 insect cells and activated in vitro
by His-tagged Src. The specific activity for the FAK used was typi-
cally 55nmol/min/mg (measured by phosphate transfer to poly
[Glu, Tyr] 4 : 1 substrate). Protein stock concentration (measured
by Bradford) was 0.39mg/ml. An AAPPTEC Apogee Peptide Syn-
thesizer (Aapptec, Louisville, KY, USA) was used for individual pep-
tide synthesis using HBTU/HOBT activation and Fmoc protected
amino acids on a 0.25g scale (amino acid loading varied from
0.27 to 0.66mmol/g). Analytical and preparative HPLC were
performed with a Phenomenex column on either an Agilent
1100 Series HPLC with Chemstation data system (Agilent Technol-
ogies, Inc., Alpharetta, GA, USA) or on a Hitachi 7000 series HPLC
(Hitachi High Technologies, Schaumburg, Illinois, USA). Automated
peptide sequencing (of single beads) was performed using an
Applied Biosystems model 476A, (Applied Biosystems Carlsbad,
CA, USA) protein sequencer. Individual beads were sandwiched
between two TFA-treated glass fiber filter discs (Applied
Biosystems, Carlsbad, CA, USA) immediately after selection from
the kinase on-bead assay and inserted directly into the sequencer.
The peptide sequences for individually synthesized, pure peptide
substrates were confirmed by Edman degradation sequencingJ. Pept. Sci. 2015; 21: 302–311 Copyright © 2015 European Peptide Society aon an AB4768 protein sequencer. Scintillation counting was per-
formed on either a Packard 1900CA Tricarb liquid scintillation
analyzer (PerkinElmer, Waltham, Massachusetts, USA) or on a
Perkin Elmer 1450 LSC and processed with Microbeta Windows
software (PerkinElmer, Waltham, Massachusetts, USA).
Synthesis
TentaGel controls—synthesis of tyrosine and Phosphotyrosine-TentaGel
beads
Two TentaGel resin controls were synthesized to determine the
best colorimetric labeling conditions with antibodies and BM
purple AP substrate. Tyrosine-TentaGel and Phosphotyrosine-
TentaGel were synthesized manually using a fritted glass peptide
synthesis reaction flask from Chemglass and employing Fmoc
amino acids with HOBT/PyBOP, DIEA for coupling, and 20%
piperdine/DMF for deprotection. Reaction completeness was
monitored via ninhydrin tests. A fourfold excess of amino acid
and coupling reagents was used relative to resin substitution.
For the phosphotyrosine analog, Fmoc-Tyr(PO(OH)2) was used
(Novabiochem). Side chain deprotection of the tyrosine-TentaGel
beads was carried out with TFA/H2O/TIS (95 : 2.5 : 2.5) for 4 h, the
resin was filtered and washed once with TFA. The beads were
washed five times with DCM, three times with 10% DIEA/DMF,
two times with DMF, once with 50 : 50 DMF/ H2O, and four times
with H2O. Additional details are available in the Supporting
Materials.
Library synthesis—preparation of the resin and synthesis of the
pentaglycine linker
A total of 2.5g (~7.15× 106 beads, 90μm) of NovaSyn TG (TentaGel)
resin (Novabiochem, substitution: 0.27mmol/g resin) was swelled
in a 25-ml glass fritted peptide reaction vessel with 4×15ml of
DMF for 30min each. The pentaglycine (Gly5) linker was
synthesized using four equivalents Fmoc-Gly-OH. The first glycine
was attached using DIC, HOBT, and DIEA (four equiv) over night,
followed by double-coupling for 3 h until the reaction was
complete by ninhydrin. The Fmoc group was removed via two
treatments with 15ml 20% piperdine/DMF for 30min. The remain-
ing four glycines were coupled to the beads using PyBOP/HOBT for
coupling and a fivefold excess of each reagent (Fmoc-Gly, PyBOP,
HOBT, and DIEA). Resin was washed six times with DMF after each
coupling and deprotection step. Reaction completeness was
assessed by the ninhydrin test.
Combinatorial peptide library synthesis—random positions using
‘split-pool’ method
Sixteen reaction tubes (10ml size) were labeled with the amino
acids to be used. The specific amino acid derivatives used in the
combinatorial positions were Fmoc-Ala-OH, Fmoc-Arg-(pmc)-OH,
Fmoc-Asn-(mtt)-OH, Fmoc-Asp-(tBu)-OH, Fmoc-Glu-(tBu)-OH, Fmoc-
Gln-(mtt)-OH, Fmoc-Gly-OH, Fmoc-His-(mtt)-OH, Fmoc-Ile-OH,
Fmoc-Leu-OH, Fmoc-Lys-(Boc)-OH, Fmoc-Met-(OH)-OH, Fmoc-Phe-OH,
Fmoc-Pro-OH, Fmoc-Trp-OH, and Fmoc-Val-OH.
The synthesized pentaglycine TentaGel beads were ‘split’
(pipetted as a slurry) into the 16 test tubes so as to evenly distribute
the resin among the tubes by volume. PyBOP, HOBT, and DIEAwere
distributed evenly among the tubes, so that each tube contained
four equivalents of each. One Fmoc amino acid (four equiv) was
added to each tube and agitated until reaction completeness was
indicated via ninhydrin test on bead aliquots removed from eachnd John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
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4reaction (3 h). The beads were then ‘pooled’, washed 4× each with
DMF and DCM, and deprotected using 20% piperdine/DMF for
45min. This split-pool procedure was followed for the remaining
randomized positions with the following changes: Coupling and
deprotection reaction times increased as the peptide chain grew
—this was monitored by the ninhydrin test on all tubes, for exam-
ple, the third library position (X) took 4 h, whereas the last coupling
was allowed to react overnight. Additionally, the last
Fmoc deprotection required a second treatment with 15ml 50%
piperdine/DMF and a 2-h reaction time.
Coupling of tyrosine in the peptide library
Four equivalents each of Fmoc-Tyr(tBu)-OH, PyBOP, HOBT, and
DIEA were added to the peptide resin with 15ml DMF. After 2.5 h,
the reaction was complete; the beads were washed with DMF,
followed by deprotection with 20% piperdine/DMF (1h), and
subsequent washing with DMF.
Library sidechain deprotection
After coupling and Fmoc deprotection of the last randomized
amino acid, the resin was washed five times with DMF, six times
with DCM, four times with 1 : 1 DCM/methanol, and once with
methanol and allowed to dry under vacuum and transferred to a
dessicator containing P2O5. Side chain deprotection was carried
out using 30ml of a cocktail containing 82.5% TFA, 5% water, 5%
anisole, 5% phenol, and 2.5% TIS at room temperature for 4 h.
The beads were filtered, rinsed once with 10ml TFA, and washed
six times with DCM and six times with methanol, and allowed to
dry on vacuum. Three beads were removed for sequencing to
determine the peptide purity of the sequence on an individual
bead. Before storage of the library, the resin was washed three
times with 10% DIEA/DMF, two times with DMF, once with 30%
H2O/DMF, once with 60% H2O/DMF, and four times with water.
Storage tubes (14) werewashed two timeswith 0.01%HCl (aq) prior
to division of the resin into these tubes (~500,000–510,000 beads
per tube). Additional information can be found in the Supporting
Materials.
Bulk peptide synthesis of positive FAK substrates
Defined peptide sequences were synthesized on 0.25 g of Wang
polystyrene resin already coupled with Fmoc-Lys(Boc)-OH
(Novabiochem, 100–200mesh, substitution: 0.27–0.66mmol/g
resin) using an AAPPTEC Apogee automatic solid-phase peptide
synthesizer under standard peptide synthesis conditions previously
stated. Coupling times were 3 h per residue. Final side chain
deprotection and resin cleavage was carried out with TFA/H2O/TIS
(95 : 2.5 : 2.5) for 4 h. The resin was filtered and washed two times
with a small amount of TFA. Water (10% v/v) was added to the
combined filtrates and the solution agitated for 1 h. The solvent
was removed in vacuo, and the crude peptide precipitated by
addition of cold ether. The precipitated peptide was washed
five times with additional cold ether. Purity was assessed via reverse-
phase HPLC on a Phenomenex 100Å, 150×4.6mm ID C18 analytical
column with a gradient of 10–100% acetonitrile in water (containing
0.1% TFA) at absorbances of 214 and 280nm over 20min
(flow rate=1.0ml/min). Analytical HPLC was followed by preparative
HPLC if necessary. Peptides used for the FAK assays were>95% pure
as determined by HPLC. Peptide sequences were confirmed by
Edman degradation sequencing on an AB4768 sequencer.wileyonlinelibrary.com/journal/jpepsci Copyright © 2015 European PePhosphorylation Assays
On-bead colorimetric labeling with control beads
A series of control reactions to determine the optimal on-bead
assay and detection conditions were performed. The assays deter-
mined variables such as the optimal blocking buffer (concentration,
pH, etc), reaction and washing volume and pH, and reaction time
with BM purple AP substrate. Additional details are available in
the Supporting Information. In general, control assays were
performed on simple TentaGel beads that contained either tyrosine
or phosphotyrosine. Optimal color differentiation was found with
the following conditions: Samples of either Y or pY on TentaGel
beads were blocked using a 1% nonfat milk solution in PBS
(10mM NaH2PO4, 150mM NaCl, pH7.4) at 37 °C for a minimum of
1h on an inverter mixer (blocking for additional time up to 6 h
had no positive or negative effect). After blocking, mouse anti-
phosphotyrosine IgG (0.5mg/ml) was added directly to the
blocking buffer and the beads agitated at room temperature for
1 h. Following the primary antibody treatment, the beads were cen-
trifuged at 4400 rpm for 1min; the supernatant was decanted and
the beads washed 3×5ml with PBS-Tween washing buffer
(10mM NaH2PO4, 150mM NaCl, pH7.4, 0.1% Tween 20), followed
by 3×5ml PBS (10mM NaH2PO4, 150mM NaCl, pH7.4). The beads
were treated with blocking buffer as before (1% nonfat milk
solution in PBS for 1 h at 37 °C), followed by the addition of the
secondary antibody AP-goat anti-mouse IgG (1mg/ml stock). The
beads were agitated for 1 h at room temperature and then washed
as before. BM purple AP substrate was added (undiluted) and the
beads mixed for 20min followed by washing with 3×5ml of water.
The antibody tagging system used here is pH sensitive, buffers
must be pH7.2–7.4, and the optimal reaction time with BM Purple
AP substrate is 15–20min.
In vitro on-bead FAK activity assay
Two aliquots of the synthesized peptide library (XXYXXXGGGGG-
TentaGel) containing approximately 500,000 beads each
(~1,000,000 total) were placed into separate plastic screening
columns—these can hold 15ml in addition to the beads. The beads
were washed 6×5ml with Tris buffer, pH7.2, and 6×5ml with FAK
kinase reaction buffer (50mM Tris [pH7.2], 10mM MgCl2, 1mM
MnCl2). To the beads, 250μL of a 10× stock of FAK kinase reaction
buffer (500mM Tris [pH7.2], 100mM MgCl2, 100mM MnCl2),
250μL of a 10× BSA solution (10mg/ml), 50μL 100mM ATP,
100μL 0.195mg/ml active FAK enzyme solution (Life Technolo-
gies), and 1.85ml water were added (total volume 2.5ml). The
library was agitated for 30min by gentle shaking on a vortex mixer
followed by FAK denaturing by heating for 10min in a 90 °C water
bath. The beads were washed for 10min using 3×5ml PBS-Tween
washing buffer (10mM NaH2PO4, pH7.4; 150mM NaCl; 0.1%
Tween 20) and 3×5ml PBS (10mM NaH2PO4, pH7.4; 150mM
NaCl). Beads were subjected to blocking buffer for 1 h using 2ml
of a 1% (w/v) nonfat milk solution in PBS (10mM NaH2PO4,
150mM NaCl, pH 7.4) at 37 °C. A 50μL aliquot of 0.5mg/ml mouse
anti-phosphotyrosine IgG (Zymed Laboratories, Inc.) was added to
the blocking buffer, and the beads were agitated at room temper-
ature for 1 h. The beads were washed 3×5ml PBS-Tween washing
buffer followed by 3×5ml PBS for 5min each. A secondary anti-
body solution composed of 100μL of 0.5mg/ml AP-goat anti-
mouse IgG (Zymed Laboratories, Inc.) prepared in blocking buffer
was added to the beads and mixed for 1 h at room temperature
and then washed as before. Undiluted BM purple AP substrateptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2015; 21: 302–311
Figure 1. One-bead one-peptide combinatorial library design.
Hexapeptides were synthesized on TentaGel resin with a poly-glycine
spacer. In order to refer to a specific randomized position (X), the library is
numbered relative to the phosphorylatable tyrosine (Y) residue.
FAK SUBSTRATE PEPTIDES(4ml, Roche Applied Science) was added to the beads, and the
suspension was mixed for 20min followed by three washes with
5ml of water. Those beads that presented a purple color
(phosphorylated peptide sequence) were identified and sorted
using a syringe needle and micro forceps under a standard
dissectingmicroscope. Selected beads were individually sandwiched
between two TFA-treated glass fiber filter discs (Applied Biosystems)
and peptide sequenced by Edman degradation on an Applied
Biosystems 476A protein sequencer.
Solution-based FAK kinetic assays of peptide substrates with [γ-32P]
ATP
All in vitro kinase reactions (30μL) were performed at 30 °C with
0.2μg FAK (Life Technologies) in kinase reaction buffer (50mM Tris
[pH7.2], 10mM MgCl2, 1mM MnCl2, and 1mg/ml BSA). To
determine Michaelis–Menton kinetics on the various peptide
substrates containing a C-terminal polylysine tail, a saturating
concentration of ATP (200μM) supplemented with 1000 cpm/pmol
[γ-32P] ATP (MP Biomedicals) was used. Initial peptide activity
screening conditions used 300μM peptide and 100μM ATP sup-
plemented with 1000 cpm/pmol [γ-32P] ATP. For peptide kinetic
studies, varying concentrations of peptide were used, ranging
from 0.125 to 8× the KM value. Reactions were initiated by the
addition of kinase and quenched after 15min by spotting
25μL of the 30μL total reaction volume onto a piece of
Whatman 2.5 cm phosphocellulose (p81) paper. Filter papers
were washed for 30min with 10% acetic acid followed by three
10-min washes with 0.5% phosphoric acid and a final 5-min
wash with acetone. The washed and dried filter discs were
placed into scintillation vials with 5ml scintillation fluid, and
32P incorporation was measured on a Packard 1900CA Tricarb
liquid scintillation analyzer or a Perkin Elmer 1450 LSC analyzer.
Kinase reactions were performed in triplicates and background
subtracted (standard error <15%). KM and Vmax values were
determined by double-reciprocal plots, constructed from initial
rate measurements fitted to the Michaelis–Menton equation.30
5Results
Previous studies have established the utility of one-bead one-
peptide combinatorial libraries in the identification of bioactive
peptides [33]. These include novel peptide-based substrates for
kinases such as those determined for the protein tyrosine kinase
c-Src using radioisotopic labeling for detection of the phosphory-
lated beads [34,35]. Active peptide substrates were also determined
via a combinatorial library assay followed by colorimetric labeling
using antibody tagging for the tyrosine kinases c-Src and ZAP-70
[36]. Using a similar approach, we likewise merged the use of a
large combinatorial solid-phase one-bead one-peptide library
with a colorimetric antibody tagging system (to eliminate the
use of radioactivity) and applied this approach to a previously
uncharacterized protein tyrosine kinase, FAK.
Combinatorial Library Design and Synthesis
The combinatorial peptide library was synthesized by the ‘split-
pool’ method as previously described [37,35,38]. The sequence of
this library was XXYXXX-GGGGG-TentaGel, where Y represents the
tyrosine residue and X represents any random amino acid with
the exception of tyrosine, serine, threonine, and cysteine (Figure 1).
Cysteine is typically excluded from combinatorial libraries toJ. Pept. Sci. 2015; 21: 302–311 Copyright © 2015 European Peptide Society aprevent disulfide bond formation in the library. The other excluded
amino acids (S, T, and Y) all contain a hydroxyl group; these were
omitted from the library so that only one possible site for phosphor-
ylation by FAK would be present, that being the ‘set’ tyrosine
at position 0. Poly(ethylene glycol)-grafted polystyrene resin,
TentaGel-S-NH2, was used as the solid-phase support, because the
PEG linker is beneficial to the aqueous environment during the
kinase assay and antibody screening system. Although the
TentaGel resin contains a flexible PEG linker, many researchers
use short ‘peptide spacers’ before the combinatorial library
positions—options for these spacers include multiple β-alanine
residues or glycine residues [39–42]. Here, the library was tethered to
TentaGel by a spacer peptide of five glycine residues. This C-terminal
poly-glycine spacer ensures that the solid support does not
interfere with the enzymatic reaction and downstream colorimet-
ric detection.
The number of unique sequences possible is slightly over 1million
(165 = 1,048,576). The synthesized library was designed with
two randomized positions (Y-1 and Y-2) N-terminal and three
randomized positions (Y + 1, Y + 2, and Y + 3) C-terminal to the
tyrosine residue. Many studies have shown that protein tyrosine
kinases display a strong preference for amino acids at the Y+ 3
position and very little preference at the Y-3 position [43].
Ultimately, the library was kept at a hexapeptide length (XXYXXX)
in order to find short, minimal length peptides that could act as
effective substrates for FAK.
Library Verification: Sequencing of Control Beads
Peptide bead sequencing was performed on three of the beads
from the synthesized library before reaction with FAK. There is
approximately 100pmol (or 1013 copies) of the same peptide
on each bead (90μM size TentaGel) [37,44]. Amounts as low as
1–5pmol of amino acid are commonly detected with Edman
degradation sequencing. Our results confirmed that a single bead
from the synthesized library contains enough amino acid at each
position for sequencing and that each bead contains one unique
peptide. The unique peptide sequences obtained from these
control beads were (i) QFYNPG-GGGGG, (ii) IFYIHK-GGGGG, and
(iii) ARYELW-GGGGG. The sequences also show the diversity of
amino acids possible at each position in the library, because a
total of 13 unique amino acids were determined at the five
randomized positions in these three peptides.
Library Screening to Identify Peptide Substrates for FAK
Once synthesized, the library beadswere reactedwith FAK andATP.
A variety of different techniques have been previously employed to
screen for kinase activity using one-bead one-peptidend John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
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6combinatorial libraries and are summarized in the review by Lee
et al. [45]. In our study, the FAK-phosphorylated peptide beads were
detected using a colorimetric antibody tagging system developed
by Martin and Peterson [46]. This colorimetric method mimics an
on-bead ELISA assay and was used in their study on two peptides
that were known substrates for the tyrosine kinase Abl. In our study,
the labeling conditions were optimized for FAK. Briefly, for this
detection system, a primary anti-phosphotyrosine IgG will recognize
whether the peptide substrate is phosphorylated by FAK. A
secondary antibody conjugated with AP will recognize the
primary antibody and react with the BM purple AP substrate. If
the peptide substrate was phosphorylated, then the bead will
appear purple under a standard dissecting microscope (Figure 2).
Control reactions were performed to determine the ideal
conditions for the antibody tagging system using different
concentration of antibody, formulation and pH of the blocking
buffer, reaction pH, reaction and labeling times, and number of
washing steps. No false positive beads (nonspecific labeling) were
obtained during these control reactions, verifying that the
bead would only turn purple when the peptide contained
phosphotyrosine. Before the library was reacted, labeling
experiments were performed on two sets of control beads: (i)
tyrosine-TentaGel beads and (ii) Phosphotyrosine-TentaGel beads,Figure 2. This scheme shows the approach used to identify peptide
substrates for the protein tyrosine kinase, focal adhesion kinase (FAK). (A)
The combinatorial peptide library was reacted with FAK and ATP. (B) The
library beads were subjected to a colorimetric antibody tagging system
and BM Purple alkaline phosphatase (AP) substrate whereby
phosphorylated beads turned purple and were selected under a
microscope. Selected beads were sent for Edman degradation peptide
sequencing to determine the identity of the FAK substrates.
wileyonlinelibrary.com/journal/jpepsci Copyright © 2015 European Pein order to optimize the conditions such that the most dramatic
color difference between phosphotyrosine and tyrosine was
produced (Figure 3).
In order to determine the optimal short peptide sequences that
would serve as efficient substrates for FAK, we desired to limit the
number of positive or ‘hit’ peptides from the library screen to ap-
proximately 10–20 sequences. The efficiency with which FAK phos-
phorylates the library peptides was determined by three control
time-dependent reactions of approximately 250,000 beads each.
The library beads were reacted with FAK for 1, 2, and 24h and re-
sulted in 29, 62, and 85 purple beads, respectively.
To verify that the stained beads could be sequenced directly
without additional washing steps, one purple bead was selected
(from the 1h reaction) and sequenced. A clean peptide sequence
resulted (IAYDEL-GGGGG) indicating no additional washing or
protein denaturation steps were needed to remove protein,
antibodies or BM purple from the resin. Based on these experi-
ments, the length of time to react the peptide library with FAK
was set at 30min. A larger aliquot of the library (~1,000,000 beads)
was chosen for this final FAK substrate library screen.Figure 3. TentaGel beads were subjected to phosphotyrosine labeling as
described in the Materials and Methods section. (A) Tyrosine-TentaGel
beads treated with mouse anti-phosphotyrosine antibody, AP-goat anti-
mouse IgG, and BM Purple AP substrate, these beads showed no signs of
purple staining. (B) Phosphotyrosine-TentaGel beads treated as above,
these showed dark purple staining. (C) Library assay with focal adhesion
kinase followed by colorimetric labeling as described. Only the darkest
purple beads were counted as focal adhesion kinase substrates, these
were selected and sequenced.
ptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2015; 21: 302–311
Table 1. Peptide sequences determined via Edman degradation
sequencing of the 12 positive beads selected from the 30min FAK
reaction with the synthesized library
Peptide Library
FAK Substrates
Position
Y-2 Y-1 Y Y + 1 Y + 2 Y + 3
LIB1 N V Y E I M
LIB2 G I Y F H E
LIB3 G E Y V V D
LIB4 M K Y M P Q
LIB5 W N Y L I H
LIB6 I D Y V E W
LIB7 I N Y E L P
LIB8 G I Y A R K
LIB9 E L Y Q N P
LIB10 L R Y F W E
LIB11 G K Y R M V
LIB12 X* D Y E L F
The amino acid present at position Y-2 (X*) in LIB12, shown in bold, was
not determined because of an instrument failure. The pentaglycine
tail is omitted for clarity. The phosphorylatable tyrosine residue, Y,
is shown in bold.
Table 2. Thirteen peptides were synthesized individually based on the
peptide sequences determined following the library reaction with FAK
Synthesized
peptides
Position
Y-2 Y-1 Y Y + 1 Y + 2 Y + 3 Polylysine tail
LIB1 N V Y E I M KKK
LIB2 G I Y F H E KKK
LIB3 G E Y V V D KKK
LIB4 M K Y M P Q KKK
LIB5 W N Y L I H KKK
LIB6 I D Y V E W KKK
LIB7 I N Y E L P KKK
LIB8 G I Y A R K KKK
LIB9 E L Y Q N P KKK
LIB10 L R Y F W E KKK
LIB11 G K Y R M V KKK
LIB12a G D Y E L F KKK
LIB12b I D Y E L F KKK
These peptides were synthesized on Wang resin and cleaved from
the solid support. Each incorporated the use of a polylysine tail
on the C-terminus in order to employ a phosphocellulose paper-
binding assay. The phosphorylatable tyrosine residue, Y, is shown
in bold.
Figure 4. Library peptide hits assayed with FAK tyrosine kinase and γ-[32P]
ATP in a solution-phase phosphocellulose paper binding assay and counted
on a liquid scintillation counter. Phosphorylation activity (incorporation of
32P) is corrected for background and shown as cpm. Data are the average
of triplicate trials. Peptide concentration for this assay was 300 μM. All
peptides assayed displayed activity as FAK substrates.
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7The library beads were then subjected to FAK for 30min, and 12
highly positive beads (dark purple) were identified, selected, and
sent for sequencing by Edman degradation sequencing (Figure 3).
Table 1 summarizes the peptide sequences originating from the
12 positive beads in the FAK library assay. All but one peptide bead
gave a complete and clean sequence. The amino acid residue at the
Y-2 position of LIB12 was not determined because of instrument
malfunction.
Analysis of the peptide substrate sequences from the library
screen showed that FAK selects substrates containing negatively
charged amino acids (glutamate and aspartate), these occurred
11 times overall in the sequences as opposed to positively charged
amino acids (K and R), which occurred only five times. This finding is
in agreement with previous studies that showed many protein
tyrosine kinases (Src, Lyn, Syk, and Abl) have a preference for acidic
residues flanking the phosphorylation site [47–50]. Additionally,
our results indicated that N-terminal positions Y-1 and Y-2 had a
preference for bulky hydrophobic residues, such as isoleucine,
leucine, and valine, which occurred seven times, or for
glycine (four occurrences). FAK selected for aromatic residues
(phenylalanine and tryptophan) more frequently at the C-terminus
rather than the N-terminus (five occurrences vs one). From the
peptides with complete sequences (LIB1–LIB11), the two most
common amino acids at the Y-2 position were glycine and isoleu-
cine with four and two occurrences, respectively. The observed
preference for isoleucine or glycine at the Y-2 site was used to
justify the design of two new peptide sequences (LIB12a and
LIB12b) to compensate for the loss of data at this position during
Edman sequencing on one of the library ‘hit’ beads, X*DYELF.
Hit Validation by Kinetic [γ-32P] ATP Assays
The resulting peptide sequences (LIB1–LIB12b) identified by the
one-bead one-peptide combinatorial library were synthesized in
bulk onWang resin to generate enoughmaterial for solution-based
validation studies. These studies utilized [γ-32P] ATP in order to
validate the library hits and compare Michaelis–Menton kinetics.J. Pept. Sci. 2015; 21: 302–311 Copyright © 2015 European Peptide Society aTo facilitate the radioactive kinetics assay, each peptide sequence
was synthesized with a C-terminal poly-lysine tail to promote
peptide binding to phosphocellulose paper via electrostatic
interactions. For in vitro kinase assays, the use of positively charged
amino acids (arginine and lysine) at the C-terminus of a kinase
substrate is well known [51,52]. Overall, 13 novel peptides were
synthesized; these sequences are summarized in Table 2.
In the kinetic assays, all 13 peptides tested were validated as
substrates for FAK bymeasuring the amount of 32P incorporated onto
the FAK peptide substrate using liquid scintillation counting. An
activity profile of all peptides tested is shown in Figure 4. The highest
scintillation counts (average of triplicate runs, peptide concentration
300μM) were found in peptides LIB1, LIB6, LIB12a, and LIB12b. Innd John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
Table 4. Peptide sequences designed as FAK substrates based on ac-
tivity determined from the active peptides from the library screen
Peptide designation Peptide sequence
DES1 IDYVEF-KKK
DES2 IDYELW-KKK
DES3 GDYVEW-KKK
DES4 GDYVEF-KKK
DES5 EDYELF-KKK
These five peptides were synthesized as described in the Materials and
Methods section and treated with FAK to evaluate their ability to act
as FAK phosphoacceptors.
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8order of activity, these sequences are as follows: LIB6 (IDYVEWKKK),
LIB12b (IDYELFKKK), LIB12a (GDYELFKKK), and LIB1 (NVYEIMKKK).
From the radioisotopic data, the general activity trends for FAK
substrates were classified into three common areas as follows: (i)
negatively charged amino acids were preferred flanking the
tyrosine residue (Y-1 and/or Y+1), (ii) there was an increase in
hydrophobic andbulky groups (isoleucine, leucine, andphenylalanine)
at positions Y + 2, and Y + 3, and lastly, (iii) an additional aromatic
amino acid residue (phenylalanine and tryptophan) was present
in three of the active substrates.
Michaelis–Menton kinetic analysis was performed on the four
most active peptide substrates discussed earlier. Individual data
points were averaged and plotted in a double-reciprocal plot to
extract KM and Vmax values and shown in Table 3. The most active
peptide tested was LIB6 with a calculated efficiency (Vmax/KM)
twofold greater than LIB12b and approximately 7.5-fold greater
than the other most active library peptides tested. The KM of
IDYVEWKKK (LIB6) was in the mid micromolar range (318μM),
and although there are peptide substrates for some well-studied
kinases (i.e., Src and Abl) that have lower reported KM values, a
KM ~300μM for FAK may prove to be useful. Although this lead
peptide does not exhibit as tight of binding as desired, these data
allow for the design of a second generation of peptide substrates
for FAK.Figure 5. Focal adhesion kinase activity comparison profile of the original
library peptide hits, shown in blue bars, with the newly designed peptides
(DES1–DES5), shown in red bars. All peptides were tested in triplicate at
the same concentration (300μM) as described in the Materials and
Methods section.
Table 5. The kinetic values for the DES peptides designed as FAK
substrates
Peptide Sequence KM
(μM)
Vmax
(nmol/ min/ mg)
Efficiency
(Vmax/KM)
DES1 IDYVEF-KKK 319 2051 6.4
DES2 IDYELW-KKK 987 911 0.92
DES3 GDYVEW-KKK 223 2430 10.9
DES4 GDYVEF-KKK 92 1920 20.9
DES5 EDYELF-KKK 404 785 1.94
Data represent the means of three separate determinations. Standard
error for all reported kinetic constants is ≤15%.Development and Screening of Second Generation Peptide
Substrates for FAK
A total of five second generation potential FAK substrates were
designed (prefix DES-) and synthesized based on the previous
kinetic data. Each of these peptides followed the library sequence
(XXYXXX) but incorporated negatively charged (aspartate and
glutamate), hydrophobic (isoleucine, leucine, and valine), and
aromatic (phenylalanine and tryptophan) residues at various
positions derived from the most active substrates selected during
the library screen and subsequent kinetic analysis (Table 4).
The new designed peptides were assayed by the previously
mentioned kinetics assay with FAK and γ-[32P] ATP, and the activity
was compared between all peptides tested (Figure 5). Based on the
findings, the best FAK substrate was DES4 (KM=92μM) with the se-
quence GDYVEFKKK. In fact, the activity of both DES3
(GDYVEWKKK, KM=223μM) and DES4 surpassed the most active li-
brary hit peptide, LIB6 (KM=318μM). These kinetic data indicate
that the overall efficiency of DES4 is two times greater than that
of LIB6 (Table 5). Additionally, all of the designed peptides had ac-
tivity higher than nine of the original library hit peptides. DES3
had comparable efficiency with LIB6. The next most active sub-
strates were DES1 and LIB12b.Table 3. Kinetic analysis of the fourmost active FAK substrate peptides
determined from the initial combinatorial library assay
Peptide Sequence KM (μM) Vmax
(nmol/min/mg)
Efficiency
(Vmax/KM)
LIB1 NVYEIM-KKK 609 861 1.41
LIB6 IDYVEW-KKK 318 3341 10.5
LIB12a GDYELF-KKK 813 1189 1.46
LIB12b IDYELF-KKK 503 2532 5.0
Data represent averages of triplicate runs. Standard error for all
reported kinetic constants is ≤15%.
wileyonlinelibrary.com/journal/jpepsci Copyright © 2015 European PeDiscussion
The identification of high affinity peptide-based probes has impor-
tant utility in a variety of enzyme-based activity and competition as-
says. One of the first Src-specific peptide substrates found, ‘RR-Src’
(RRLIEDAEYAARRG, KM=2.8mM), was designed based upon Src’s
autophosphorylation site and was routinely used for activity
assays [53]. The usefulness of an active peptide substrate for a given
protein kinase can lead to high throughput screening methods
for kinase inhibitors as shown by the utility of the Src substrate
Ac-IYGEFKKKC-NH2 that was conjugated to a peptide chip andptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2015; 21: 302–311
FAK SUBSTRATE PEPTIDESanalyzed for kinase and inhibitor activity by phosphoimaging [54].
For the protein kinase Src, short peptides were identified via
combinatorial peptide library methods, providing sequences
YIYGSFK and GIYWHHY with KM values of 55 and 20μM, respec-
tively [35,34]. Besides Src, other tyrosine kinases have been
analyzed by combinatorial libraries, for example, Abl’s specificity
was analyzed by means of a one-bead one-peptide library where
14 unique Abl substrates were identified and grouped into three
substrate motifs [47].
Methods other than synthetic combinatorial peptide libraries
have been used to screen for kinase substrates. Phage peptide
expression libraries have emerged as a method to determine
peptide substrate motifs, and this approach has been applied to
the Src-family protein kinases Blk, Lyn, Fyn, and Src [55]. In one
study, the phage peptide library identified a novel Fyn peptide
substrate EFGTYGTLS with a KM=70μM [56].
If no specific substrate is known for a kinase, a random poly-
mer of Glu and Tyr in the ratio of 4 : 1 can be used for enzyme
activity assays [48]. This poly (Glu4, Tyr1) lacks a defined phos-
phorylation site or higher orders of structure and is commonly
used as a generic tyrosine kinase substrate. Therefore, the
activity of a kinase for this polymer is considered as general
kinase activity, lacking in specificity or selectivity, and it does
not add to the understanding of an enzyme’s active site selec-
tivity for specific substrates.
To date, a peptide substrate analysis of FAK via any method,
combinatorial or otherwise, has not been reported. In this study,
a combinatorial one-bead one-peptide library was synthesized
and used to screen for FAK substrates using an on-bead kinase
assay and colorimetric detection method. Edman degradation
was performed on beads shown to be phosphorylated revealing
12 hit peptide sequences. These peptide substrates were
resynthesized and validated by solution-phase radioisotopic label-
ing for kinetic evaluation. Based on results from the initial library
hits, five additional peptides were designed and found to be
efficiently phosphorylated by FAK. The best substrates wereTable 6. Activity ranking for all peptides identified in this study
Activity ranking Peptide Sequence Efficienc
Most active DES4 GDYVEF-KKK 2
DES3 GDYVEW-KKK 1
LIB6 IDYVEW-KKK 1
Second tier DES1 IDYVEF-KKK
LIB12b IDYELF-KKK
Third tier DES5 EDYELF-KKK
LIB12a GDYELF-KKK
LIB1 NVYEIM-KKK
DES2 IDYELW-KKK
Other library hits LIB2 GIYFHE-KKK Kinetic constant
LIB4 MKYMPQ-KKK
LIB7 INYELP-KKK
LIB8 GIYARK-KKK
LIB5 WNYLIH-KKK
LIB3 GEYVVD-KKK
LIB9 ELYQNP-KKK
LIB10 LRYFWE-KKK
LIB11 GKYRMV-KKK
Peptides were grouped according to their substrate activity with focal ad
kinase was DES4, GDYVEFKKK is shown in bold.
J. Pept. Sci. 2015; 21: 302–311 Copyright © 2015 European Peptide Society athose determined to have negatively charged amino acids as
well as bulky hydrophobic or aromatic amino acids near the
tyrosine. The most active peptide substrate for FAK was DES4
(GDYVEF-KKK) with a KM=92μM. This substrate may serve as a
useful tool for FAK-specific activity and competition assays.
Further, a consensus sequence for active FAK substrate peptides
can be summarized as G/I-D-Y-V-E-F/W. Placing the peptide
sequences determined in this study into activity tiers provides
us a better picture of FAK substrate specificity (Table 6).
The determination of efficient substrates for FAK advances signal
transduction research by providing researchers with an effective
probe for monitoring the activity of this enzyme. All of the peptides
analyzed here, both from the initial library screen and from the
designed peptides, displayed activities higher than that reported
for the generic poly [Glu, Tyr] 4 : 1 substrate. (The specific activity
for FAK was reported as 55 nmol/min/mg, measured by phosphate
transfer to poly [Glu, Tyr] 4 : 1 substrate.) Peptides in this study had
Vmax activities that ranged from 785 to 3341nmol/min/mg. This
increase in phosphoacceptor ability of the peptide substrates
reported here likewise increases the sensitivity of FAK activity as-
says andmay lead to enhanced screening capabilities for FAK inhib-
itors, as well as the design of novel non-ATP competitive inhibitors.
The identification of peptide substrates for other protein kinases
has led to the development of peptide biosensors. Recent studies
with peptide-based Abl and Syk biosensors have demonstrated
feasibility in monitoring pharmacodynamic effects within a live cell
model [57,58]. The translation of these efficient FAK peptide
substrates into effective biosensors may shed light onto how FAK
is able to sense and transduce signals within a cell, providing a tool
for researchers to further address questions regarding the role of
FAK in promoting tumorigenesis or metastasis.
Lastly, these substrates offer an increased understanding of the
active site for this important kinase. The crystal structure of FAK
has been solved with ATP bound, but little evidence has been
reported on how a protein (or peptide) substrate binds in the
active site [59]. The peptide substrates reported here launchy (Vmax/KM) Comments/consensus
0.9 GDYVE-aromatic
0.9 IDYVE-aromatic
0.5
6.4 IDYVE-aromatic
5.0 IDYEL-aromatic
1.94 X-Y-E-I/L-aromatic/M
1.46
1.41 X varies: negative, small, hydrophobic
0.92
s not determined Ranked in relative activity order from initial
peptide profile assay
hesion kinase. Themost active peptide substrate for focal adhesion
nd John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
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0the possibility for addressing important questions about the
landscape of FAK’s active site, the potential binding modes for
substrates, and the development of new FAK inhibitors as novel
anticancer therapeutics.
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